Literature DB >> 27802475

Giant Cell Arteritis.

Gary S Hoffman.   

Abstract

This issue provides a clinical overview of giant cell arteritis, focusing on diagnosis, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27802475     DOI: 10.7326/AITC201611010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

Review 1.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 2.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

3.  Necessity of Temporal Artery Biopsy for Giant Cell Arteritis: A Systematic Review.

Authors:  Brett Ponich; Rebecca Hartley; Ann-Sophie Lafreniere; Claire F Temple-Oberle
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-20

4.  Giant cell arteritis manifested by chronic dry cough.

Authors:  Hiroshi Hori; Tsuyoshi Kobashigawa; Takahiko Fukuchi; Hitoshi Sugawara
Journal:  BMJ Case Rep       Date:  2020-06-21

5.  Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.

Authors:  Sergio Prieto-González; Nekane Terrades-García; Marc Corbera-Bellalta; Ester Planas-Rigol; Chie Miyabe; Marco A Alba; Ariel Ponce; Itziar Tavera-Bahillo; Giuseppe Murgia; Georgina Espígol-Frigolé; Javier Marco-Hernández; José Hernández-Rodríguez; Ana García-Martínez; Sebastian H Unizony; Maria C Cid
Journal:  RMD Open       Date:  2017-12-22

6.  Ischemic Optic Neuropathy in a Dog with Acute Bilateral Blindness and Primary Systemic Hypertension.

Authors:  L Mari; R Stavinohova; E Dominguez; J Premont; J Oliver; L De Risio
Journal:  J Vet Intern Med       Date:  2017-11-12       Impact factor: 3.333

7.  Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.

Authors:  Georgina Espígol-Frigolé; Ester Planas-Rigol; Ester Lozano; Marc Corbera-Bellalta; Nekane Terrades-García; Sergio Prieto-González; Ana García-Martínez; Jose Hernández-Rodríguez; Josep M Grau; Maria C Cid
Journal:  Front Immunol       Date:  2018-04-20       Impact factor: 7.561

8.  Simultaneous Presentation of Giant Cell Arteritis and Myelodysplastic Syndrome in an Elderly Japanese Man.

Authors:  Hajime Senjo; Takakazu Higuchi; Masaya Morimoto; Ryosuke Koyamada; Chisun Yanaoka; Sadamu Okada
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

9.  A Stab in the Dark: A Case Report of an Atypical Presentation of Giant Cell Arteritis (GCA).

Authors:  Beth McCausland; David Desai; David Havard; Yasmin Kaur; Asalet Yener; Emma Bradley; Harnish P Patel
Journal:  Geriatrics (Basel)       Date:  2018-06-29

10.  Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK.

Authors:  Sara Gale; Jessica C Wilson; Jenny Chia; Huong Trinh; Katie Tuckwell; Neil Collinson; Sophie Dimonaco; Susan Jick; Christoph Meier; Shalini V Mohan; Khaled Sarsour
Journal:  Rheumatol Ther       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.